MUFG Securities EMEA plc Sells 43,765 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS)

MUFG Securities EMEA plc lowered its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 82.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,235 shares of the company’s stock after selling 43,765 shares during the period. MUFG Securities EMEA plc’s holdings in Nu Skin Enterprises were worth $455,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the business. Delek Group Ltd. purchased a new position in Nu Skin Enterprises during the 1st quarter valued at about $17,859,000. Dupont Capital Management Corp increased its holdings in Nu Skin Enterprises by 30.6% during the 2nd quarter. Dupont Capital Management Corp now owns 5,978 shares of the company’s stock valued at $295,000 after purchasing an additional 1,400 shares during the period. Trexquant Investment LP increased its holdings in Nu Skin Enterprises by 7.0% during the 1st quarter. Trexquant Investment LP now owns 27,914 shares of the company’s stock valued at $1,336,000 after purchasing an additional 1,829 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in Nu Skin Enterprises by 3.4% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 562,247 shares of the company’s stock valued at $27,731,000 after purchasing an additional 18,544 shares during the period. Finally, Prescott Group Capital Management L.L.C. increased its holdings in Nu Skin Enterprises by 411.2% during the 1st quarter. Prescott Group Capital Management L.L.C. now owns 174,194 shares of the company’s stock valued at $8,337,000 after purchasing an additional 140,121 shares during the period. 73.95% of the stock is owned by hedge funds and other institutional investors.

Nu Skin Enterprises stock traded up $0.19 during trading hours on Friday, hitting $44.47. 18,422 shares of the stock traded hands, compared to its average volume of 526,845. The firm’s 50-day moving average price is $40.56 and its two-hundred day moving average price is $48.47. The company has a current ratio of 1.90, a quick ratio of 1.20 and a debt-to-equity ratio of 0.52. The company has a market cap of $2.43 billion, a PE ratio of 12.59, a PEG ratio of 1.45 and a beta of 0.77. Nu Skin Enterprises, Inc. has a one year low of $35.03 and a one year high of $85.75.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.83 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.83. The business had revenue of $623.50 million for the quarter, compared to analysts’ expectations of $622.32 million. Nu Skin Enterprises had a return on equity of 24.73% and a net margin of 4.79%. The business’s revenue was down 11.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.95 EPS. On average, sell-side analysts expect that Nu Skin Enterprises, Inc. will post 3.26 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 11th. Stockholders of record on Friday, August 30th were given a $0.37 dividend. The ex-dividend date of this dividend was Thursday, August 29th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 3.33%. Nu Skin Enterprises’s dividend payout ratio is currently 42.05%.

A number of brokerages recently issued reports on NUS. DA Davidson boosted their price target on Nu Skin Enterprises to $42.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Jefferies Financial Group downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating and set a $40.00 price target on the stock. in a report on Wednesday, July 17th. Bank of America restated an “underperform” rating and set a $52.00 price target (down previously from $57.00) on shares of Nu Skin Enterprises in a report on Wednesday, June 19th. Stifel Nicolaus set a $39.00 price target on Nu Skin Enterprises and gave the company a “sell” rating in a report on Wednesday, August 7th. Finally, Pivotal Research restated a “buy” rating and set a $70.00 price target on shares of Nu Skin Enterprises in a report on Wednesday, August 7th. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $53.75.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Featured Article: What is the Fibonacci sequence?

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit